Clinical Trial Update: YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating YH001 plus Envafolimab with or without doxorubicin in advanced or metastatic sarcoma (including soft tissue sarcoma). Stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Envafolimab (envafolimab)
• YH001 (YH001)

Snippet

Sponsor: Tracon Pharmaceuticals Inc. | Conditions: Advanced Sarcoma, Metastatic Sarcoma | Phase 1, Phase 2 | Status: UNKNOWN